Diagnostic Strategies for Treatment Selection in Advanced Prostate Cancer.

Diagnostics (Basel) · 2021 · PMC7922176 · PMID 33669657

Europe PMC DOI

hedged sentence

0.3000

closest p · 6.0× alpha

0.3000

boldest claim

The sentences

did not reach statistical significancep = 0.3not close (p > 0.1)

GETUG-15 reported an absolute difference in median overall survival (OS) of 14 months; however, the benefit did not reach statistical significance (62.1 vs. 48.6 months; hazard ratio (HR): 0.88; 95% confidence interval [CI]: 0.68–1.14; p = 0.3) and the trial was negative [ 53 ].

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.